The Nigeria Institute of Medical Research has finalised the process for a successful implementation of the 2018 Drug Therapeutic Efficacy Studies (DTES).
This was stated after a successful 3-Day workshop was organised in conjunction with the National Malaria Elimination Program (NMEP).
Major participants in the workshop held last month were, principal investigators from the selected sites and three team members from each site (Microscopists, Nurses and Data Managers)
Also in attendance were staffs from WHO, NIMR, NMEP and other Roll Back Malaria partners.
Newsheadline247 understands the implementation of the 2018 DTES will be carried out in three selected sites; Kano, Plateau and Enugu states.
Professor Babatunde Lawal Salako, the Director-General of the Nigerian Institute of Medical Research (NIMR) in his welcome address emphasised on the importance of the DTES and the key role the NIMR will play in its implementation in the coming years.
The highlight of his address are changes that NIMR will introduce into the current DTEs including the signing of Sub-awards with PIs, the need for PIs to provide guarantors and evidence of having completed the NIH certificate course on Ethics
Porf. Salako later introduced Prof. Mokolu as one of the Consultants appointed for the 2018 DTES while Dr Sam. Awolola was appointed as the DTEs Program Director in NIMR.
However, Dr. Sam Awolola, NIMR DTEs Director presented the overview of the DTEs organization, responsibility and timelines.
He also reiterated the importance of the workshop as it will help to harmonize activities at the three sites. He informed participants of the DTEs management platform.
Dr Awolala stated that while NIMR manages the DTES sites with the PIs, the NMEP coordinate and provide oversight function. He listed the roles of other partners and funders and outlined the structure the workshop will take to include plenary and breakout sessions.
